Nicholas Carlson
Business Insider
December 10, 2012

Drug company Novartis is betting $20 million on a cancer treatment that seems to have saved a little girl’s life, according to a report from The New York Times’ Denise Grady.

Just last spring, six-year-old leukemia victim Emma Whitehead was “near death,” having gone through chemotherapy twice without success.

But then her parents put Emma through an experimental treatment at Children’s Hospital of Philadelphia.

They infected her with a version of HIV, reprogrammed to attack cancer cells.

Read full article